intelligence360
  • SUBSCRIBE
  • About us
  • Video News Daily
  • Contact Us
  • Search Icon

intelligence360

The Intelligent News Source

Digital Health Strategies Closes Series A Funding Round to Expand Its Share of Health™ Patient Loyalty Platform

Digital Health Strategies Closes Series A Funding Round to Expand Its Share of Health™ Patient Loyalty Platform

December 4, 2023 Craig Etkin

Data and technology investments will help DHS clients build loyalty and retention, improve care coordination and close care gaps

December 04, 2023 10:08 AM Pacific Standard Time

WASHINGTON–(BUSINESS WIRE)–Digital Health Strategies, Inc. (DHS), a healthcare-exclusive, data and technology-enabled solutions company, today announced it has closed a Series A funding round to expand its Share of Health™ patient loyalty platform. Led by healthcare industry veterans, the strategic investment will bolster the company’s data and technology solutions that help DHS clients build loyalty and retention, improve care coordination and close care gaps.

“an elder statesman in the health-care industry.”Post this

Since its founding in 2014, DHS has been on a consistent growth trajectory and recently was named to the Inc. 5000 list of fastest-growing private companies in America. The company’s clients include some of the largest health systems in the country including Geisinger, Hackensack Meridian Health and Providence Health.

With the support of the country’s most respected healthcare leaders, DHS is poised to supercharge the next phase of the company’s growth. Its investors during this round include:

  • David Schultz, Founder & CEO of MediaLogic, a nationally recognized strategic marketing firm that specializes in the healthcare, financial services and technology sectors. Mr. Schultz, the lead investor, will serve on the DHS Board of Directors, along with co-CEOs Ben Texter and John Simpson.
  • Michael H. Focht, Sr., former President, Executive Vice Chairman and Board Member, Tenet Healthcare (NYSE: THC). The Wall Street Journal has described Mr. Focht as “an elder statesman in the health-care industry.”
  • T. Dennis Jorgensen, former Senior Vice President and Chief Ethics Officer, Tenet Healthcare (NYSE: THC) and former Board Member, USC University Hospital and Tenet Healthcare Foundation.
  • Bob Dresing, former Chairman, CareMetx (acquired by The Vistria Group and General Atlantic), Founder, TheraCom (acquired by CVS Caremark) and Former CEO, Cystic Fibrosis Foundation.
  • Mark Hansan, Executive Chairman, CareMetx (acquired by The Vistria Group and General Atlantic),Co-Founder, TheraCom (acquired by CVS Caremark) and Former COO, Cystic Fibrosis Foundation.
  • Craig Goodman, healthcare consultant and investor, former Partner and COO, Lifematters, a home healthcare agency.

Barry Schochet serves as an advisor to the company’s senior management. Mr. Schochet is an operating partner at CIC Partners and the former Vice Chairman of Tenet Healthcare (NYSE: THC). Mr. Schochet also serves on the Boards of Directors of Enhabit Home Health & Hospice (NYSE: EHAB), Redina Healthcare Real Estate, and BroadJump.

“Cultivating patient loyalty is imperative as health systems have increasingly grown to own more of the continuum of care,” said Ben Texter, co-founder and co-CEO of DHS. “For years, DHS has been at the forefront of the evolving industry dynamic and, with this investment, we’ll be able to connect even more patients with the care and services they need as well as convert more grateful patients into donors.”

“Data is at the heart of everything we do,” said John Simpson, co-founder and co-CEO of DHS. “Our proprietary and highly collaborative approach to propensity modeling places a premium on incorporating the unique characteristics of the health system’s patients and operations. This enables relevant, personalized communications that meet patients’ and donors’ needs, and drives deeper, long-term relationships with our health system clients.”

The DHS data team is led by Paul Matsui, former Executive Director of Optum/The Advisory Board Company’s Data and Analytics Group and former Chief Strategy Officer of Socially Determined. Earlier in his career, Paul served as an equity research analyst at Goldman Sachs (NYSE: GS) and Citigroup (NYSE: C) covering medical technology and biotechnology.

“Our scalable, highly customized modeling services integrate seamlessly into our comprehensive suite of full-service precision marketing and fundraising solutions that help drive action and impact,” Matsui said.

For more information about Digital Health Strategies, visit www.digitalhealthstrategies.com.

For a Share of Health™ overview, visit https://www.digitalhealthstrategies.com/shareofhealthvideo/.

About Digital Health Strategies (DHS)

DHS is a data- and technology-enabled solutions company that grows “Share of Health” for health systems and health plans by maximizing the value of patient relationships to optimize care, build loyalty and grow revenue. DHS is led by John Simpson and Ben Texter who co-founded the company in 2014 after working at Blue State Digital, the digital engagement & technology agency that supported Barack Obama’s 2008 and 2012 presidential campaigns. DHS clients include some of the largest and most respected health systems in the country such as Geisinger, Hackensack Meridian Health and Providence Health. In 2023, DHS was named to the Inc. 5000 list of fastest-growing private companies in America.

Contacts

Andrew Koneschusky
(202) 670-0723
andrew@digitalhealthstrategies.com

(c)2023 Business Wire, Inc., All rights reserved.


Venture Capital
Business Wire, Digital Health Strategies, Venture Capital, Washington DC

Post navigation

NEXT
Clever Carnivore Raises $7M to Expand Operations and Scale Up Production of Cultivated Meat
PREVIOUS
Perpetual Medicines Completes $8 Million Seed Round to Advance Integrated Computational Design-Synthesis Platform for Peptide Drug Discovery
Comments are closed.
Subscribe for FREE!

intelligence360

intelligence360
Source: http://go.intelligence360.io/ and https://intelligence360.news/

Kimberly-Clark Corporation, one of the world's leading manufacturers of personal care and hygiene products, will establish an $800 million advanced manufacturing facility in Trumbull County, bringing an anticipated 491 new high-quality jobs. For Kimberly-Clark, this new facility would be its first in Ohio and represents not just a strategic expansion, but a decisive step in doubling down on growth in the American market. Spread across more than one million square feet, the Warren facility will provide the manufacturing capacity needed to unleash future growth for Kimberly-Clark’s fastest-growing personal care categories that include Baby & Child Care and Adult & Feminine Care. Warren is in geographic proximity to roughly 117 million consumers and will serve as a strategic hub for the Northeast and Midwest regions. Construction is expected to begin this month and will take up to two years.

In a statement Tamera Fenske, chief supply chain officer at Kimberly-Clark said, “Our investment in Warren is a pivotal step forward in our North America business and strategy.” “By establishing a new, state-of-the-art manufacturing facility in Ohio, we’re enhancing our ability to serve millions of consumers across the Midwest and Northeast with greater speed, agility, and resilience. It’s a once-in-a-career opportunity to build a facility from the ground up that reflects the future of manufacturing, and with the support of local partners like JobsOhio, the Department of Development, Lake to River, Western Reserve Port Authority, and local governments, we have the unique opportunity to create high-quality jobs and long-term economic impact in the region.”

Based in Dallas and employing 46,000 people in 34 countries, the company’s portfolio of brands also includes Huggies, Kleenex, Scott, Kotex, Cottonelle, Poise, Depend, Andrex, Pull-Ups, GoodNites, Intimus, Plenitud, Sweety, Softex, Viva and WypAll. Its products are sold in more than 175 countries and territories.
Source: http://go.intelligence360.io/ and https://intelligence360.news/

Snorkel AI announced general availability of two new product offerings on the Snorkel AI Data Development Platform: Snorkel Evaluate and Snorkel Expert Data-as-a-Service. These launches advance its mission to turn knowledge into specialized AI—helping teams move from prototype to production at scale by leveraging Snorkel AI’s programmatic data development technology. In addition, Snorkel AI announced it has raised $100 million in Series D funding at a $1.3 billion valuation, led by Addition. This new funding will fuel continued research and innovation in evaluating and tuning specialized AI systems with expert data.


In a statement Alex Ratner, Co-founder and CEO of Snorkel AI said, “We are seeing a surge of momentum around agentic AI, but specialized enterprise agents aren’t ready for production in most settings.” “Enterprises need domain-specific data and expertise to make this a reality. We’re excited to deliver on this need and help AI innovators develop expert data to bring their LLM and agentic systems into production with our new offerings, which round out Snorkel’s unified AI data development stack.”

Snorkel AI is building the Snorkel AI Data Development Platform for evaluating and tuning specialized AI at scale. Snorkel AI’s offerings, including Snorkel Evaluate and Snorkel Expert Data-as-a-Service, accelerate evaluation and tuning of specialized AI systems with expert data—helping teams move from prototype to production at scale by leveraging Snorkel AI’s programmatic data development technology. Launched out of the Stanford AI Lab, Snorkel AI’s platform is used in production by Fortune 500 companies, including BNY, Wayfair, and Chubb, as well as across the U.S. federal government, including the U.S. Air Force.
Source: http://go.intelligence360.io/ and https://intelligence360.news/

TicketManager, a global leader in event ticket and guest management solutions for the corporate enterprise, today announced Valeas Capital Partners, a growth-oriented private-equity firm, has acquired a majority stake in the company. Under the terms of the agreement, Valeas is committing $110 million to support TicketManager’s strategic growth plans. TicketManager Co-Founder and CEO Tony Knopp and COO Ken Hanscom will retain a minority interest in the Company. Founded in 2007, TicketManager is the category leader in providing software and services to manage end-to-end event ticket workflow and guest experiences. Serving as the central hub and system of record for data-driven organizations, the platform streamlines every step of the ticket management process. Every year, companies spend more than $600 billion on customer entertainment, yet 43% of corporate tickets are never used and fewer than 20% of organizations leverage modern software to optimize those investments and mitigate compliance risk.

In a statement Tony Knopp, CEO and Co-Founder of TicketManager said, “Live events are an important investment for businesses of all sizes. Whether major global sponsorships, naming rights for stadiums, luxury suites or even a few season tickets for the local team, companies use them to attract and keep customers while building their brands. But in today’s market, many companies struggle with growing pressure to show the value of their ticket spending.” “We knew there was a better way, and that’s why we created TicketManager – to make company tickets easy and prove the return on investment with cutting edge technology and services.”

TicketManager is a leading event- and guest-management platform that empowers companies to make client entertainment easy and drive greater return on investment. It offers convenient and simple technology to manage corporate sports and entertainment tickets, create exceptional guest life-cycle experiences, and measure effectiveness. TicketManager is trusted by more than 500 global brands including Verizon, FedEx, Adidas, Anheuser-Busch, and Mastercard.
Load More... Subscribe

Categories

Recent Posts

  • Bespoken Spirits Announces Successful Close of Series-C Funding Round June 9, 2025
  • Bito Raises $5.7M Seed Extension to Expand AI Code Review Platform with Codebase Awareness June 9, 2025
  • Pillar Biosciences Raises $34.5M in Funding June 9, 2025
  • CloudZero Raises $56M Series C To Redefine Cloud Cost Optimization In The AI Era June 9, 2025

Archives

© 2025   Copyright SI360 Inc. All Rights Reserved.